Patents Assigned to Verenium Corporation
  • Patent number: 7432098
    Abstract: The invention provides isolated and recombinant phytase enzymes. In one aspect, the phytases are produced by modification of the wild type appA of E. coli. The enzyme can be produced from recombinant host cells. The phytases of the invention can be used to aid in the digestion of phytate where desired. In particular, the phytases of the invention can be used in foodstuffs to improve the feeding value of phytate rich ingredients. The phytases of the invention can be thermotolerant and/or thermostable. Also provided are methods for obtaining a variant polynucleotide encoding a phytase and for obtaining a phytase with thermostability or thermotolerant at high or low temperatures.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: October 7, 2008
    Assignee: Verenium Corporation
    Inventors: Jay M. Short, Kevin A. Gray, Nelson R. Barton, James B. Garrett, Eileen O'Donoghue, Dan E. Robertson
  • Publication number: 20080227132
    Abstract: The invention relates to hydrolases and to polypeptides having hydrolase activity. In addition, the invention relates to the use of these hydrolase enzymes in kinetic resolution.
    Type: Application
    Filed: January 22, 2008
    Publication date: September 18, 2008
    Applicant: Verenium Corporation ( formerly Diversa Corporation )
    Inventors: Jay Short, Eric J. Mathur, Markus Baumann, Uwe T. Bornscheuer
  • Patent number: 7422876
    Abstract: The invention relates to carboxymethyl cellulases and to polynucleotides encoding the carboxymethyl cellulases. In addition methods of designing new carboxymethyl cellulases and method of use thereof are also provided. The carboxymethyl cellulases have increased activity and stability at increased pH and temperature.
    Type: Grant
    Filed: January 11, 2005
    Date of Patent: September 9, 2008
    Assignee: Verenium Corporation
    Inventors: Jay M. Short, Eric J. Mathur, David E. Lam
  • Patent number: 7416874
    Abstract: A purified recombinant phytase enzyme derived from Escherichia coli B. The enzyme has a molecular weight of about 47.1 kilodaltons and has phytase activity. The enzyme can be produced from native or recombinant host cells and can be used to aid in the digestion of phytate where desired. In particular, the phytase of the present invention can be used in foodstuffs to improve the feeding value of phytate rich ingredients.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: August 26, 2008
    Assignee: Verenium Corporation
    Inventor: Jay M. Short
  • Patent number: 7414119
    Abstract: The invention provides novel aldolases, nucleic acids encoding them and methods for making and using them, including chemoenzymatic processes for making ?,?-dihydroxyheptanoic acid side chains and compositions comprising these side chains, e.g., [R-(R*,R*)]-2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-(phenylamino)-carbonyl]-1H-pyrrole-1-heptanoic acid (atorvastatin, LIPITOR™), rosuvastatin (CRESTOR™), fluvastatin (LESCOL™), related compounds and their intermediates.
    Type: Grant
    Filed: August 19, 2003
    Date of Patent: August 19, 2008
    Assignee: Verenium Corporation
    Inventors: William Greenberg, Mark J. Burk, Alexander Varvak, Kelvin Wong
  • Patent number: 7407677
    Abstract: The invention relates to alpha amylases and to polynucleotides encoding the alpha amylases. In addition methods of designing new alpha amylases and methods of use thereof are also provided. The alpha amylases have increased activity and stability at acidic, neutral and alkaline pH and increased temperature.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: August 5, 2008
    Assignee: Verenium Corporation
    Inventors: Walter Callen, Toby Richardson, Gerhard Frey, Jay M. Short, Eric J. Mathur, Kevin A. Gray, Janne S. Kerovuo, Malgorzata Slupska
  • Patent number: 7323336
    Abstract: The invention relates to alpha amylases and to polynucleotides encoding the alpha amylases. In addition methods of designing new alpha amylases and methods of use thereof are also provided. The alpha amylases have increased activity and stability at increased pH and temperature.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: January 29, 2008
    Assignee: Verenium Corporation
    Inventors: Walter Callen, Toby Richardson, Gerhard Frey, Carl Miller, Martin Kazaoka, Jay M. Short, Eric J. Mathur
  • Patent number: 7300775
    Abstract: In accordance with the present invention there are provided methods for producing enantiomerically pure ?-substituted carboxylic acids, such as, for example, ?-amino acids and ?-hydroxy acids, said method comprising combining an aldehyde or ketone with a cyanide and ammonia or an anmionium salt or an amine, in the presence of a nitrilase or a polypeptide having nitrilase activity which stereoselectively hydrolyzes the amino nitrile or cyanohydrin intermediate under conditions sufficient to produce the enantiomerically pure ?-substituted carboxylic acid, such as, for example, ?-amino acids and ?-hydroxy acids.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: November 27, 2007
    Assignee: Verenium Corporation
    Inventors: Darcy Madden, legal representative, David Paul Weiner, Jennifer Ann Chaplin, Dan E. Robertson, Mark Madden, deceased
  • Patent number: 7294498
    Abstract: A thermostable glycosidase enzymes derived from various Thermococcus, Staphylothermus and Pyrococcus organisms is disclosed. The enzymes are produced from native or recombinant host cells and can be utilized in the food processing industry, pharmaceutical industry and in the textile industry, detergent industry and in the baking industry.
    Type: Grant
    Filed: April 9, 2002
    Date of Patent: November 13, 2007
    Assignee: Verenium Corporation
    Inventors: Edward J. Bylina, Ronald V. Swanson, Eric J. Mathur, David E. Lam
  • Patent number: 7291460
    Abstract: Methods for the sequencing of polynucleotides are provided. Also provided are multiplex systems for sequencing polynucleotides using the disclosed methods, kits for use with the disclosed methods and methods for diagnosing diseases and adverse drug reactions using the disclosed methods.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: November 6, 2007
    Assignee: Verenium Corporation
    Inventors: Mike Lafferty, Charles Tweedy, James Butler
  • Patent number: 7288400
    Abstract: The invention relates to esterases and to polynucleotides encoding the esterases. In addition methods of designing new esterase method of use thereof are also provided. The esterases have increased activity and stability at increased pH and temperature.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: October 30, 2007
    Assignee: Verenium Corporation
    Inventors: Dan E. Robertson, Dennis Murphy, John Reid, Anthony M. Maffia, Steven Link, Ronald V. Swanson, Patrick V. Warren, Anna Kosmotka, Jay M. Short, Eric J. Mathur
  • Patent number: 7279316
    Abstract: The invention relates to glycosidases and to polynucleotides encoding the glycosidases. In addition methods of designing new glycosidases and method of use thereof are also provided. The glycosidases have increased activity and stability at increased pH and temperature.
    Type: Grant
    Filed: March 6, 2002
    Date of Patent: October 9, 2007
    Assignee: Verenium Corporation
    Inventors: Jay M. Short, Edward Bylina, Ronald V. Swanson, Eric J. Mathur, David E. Lam
  • Patent number: 7273740
    Abstract: The invention relates to alpha amylases and to polynucleotides encoding the alpha amylases. In addition methods of designing new alpha amylases and methods of use thereof are also provided. The alpha amylases have increased activity and stability at increased pH and temperature.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: September 25, 2007
    Assignee: Verenium Corporation
    Inventors: Walter Callen, Toby Richardson, Gerhard Frey, Carl Miller, Martin Kazaoka, Jay M. Short, Eric Mathur